FDA 483 - Baxter Healthcare Corporation - September 28, 2021

An FDA inspection of Baxter Healthcare Corporation in Medina, NY, identified inadequate validation of medical device software. Specifically, the firm failed to perform regression testing for several Spectrum Infusion Pump software updates, which were released to address issues related to recalls. This deficiency indicates a significant lapse in ensuring software changes do not introduce unintended consequences.